- Home
- MNPR vs SB Comparison
MNPR vs SB Comparison
Compare MNPR & SB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- SB
- Stock Information
- Founded
- MNPR 2014
- SB 2007
- Country
- MNPR United States
- SB Monaco
- Employees
- MNPR N/A
- SB 941
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- SB Marine Transportation
- Sector
- MNPR Health Care
- SB Consumer Discretionary
- Exchange
- MNPR Nasdaq
- SB Nasdaq
- Market Cap
- MNPR 390.5M
- SB 479.9M
- IPO Year
- MNPR 2019
- SB 2008
- Fundamental
- Price
- MNPR $86.16
- SB $4.69
- Analyst Decision
- MNPR Strong Buy
- SB Strong Buy
- Analyst Count
- MNPR 12
- SB 1
- Target Price
- MNPR $96.64
- SB $5.00
- AVG Volume (30 Days)
- MNPR 97.3K
- SB 314.6K
- Earning Date
- MNPR 11-10-2025
- SB 11-03-2025
- Dividend Yield
- MNPR N/A
- SB 4.26%
- EPS Growth
- MNPR N/A
- SB N/A
- EPS
- MNPR N/A
- SB 0.43
- Revenue
- MNPR N/A
- SB $277,509,000.00
- Revenue This Year
- MNPR N/A
- SB N/A
- Revenue Next Year
- MNPR N/A
- SB $13.02
- P/E Ratio
- MNPR N/A
- SB $10.86
- Revenue Growth
- MNPR N/A
- SB N/A
- 52 Week Low
- MNPR $12.55
- SB $3.02
- 52 Week High
- MNPR $105.00
- SB $4.72
- Technical
- Relative Strength Index (RSI)
- MNPR 57.75
- SB 69.54
- Support Level
- MNPR $77.00
- SB $4.57
- Resistance Level
- MNPR $89.32
- SB $4.70
- Average True Range (ATR)
- MNPR 7.00
- SB 0.10
- MACD
- MNPR -1.45
- SB 0.04
- Stochastic Oscillator
- MNPR 44.25
- SB 98.18
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.